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Background: Several organizations and individual authors have been proposing quality indicators for the assessment
of clinical care in HIV/AIDS patients. Nevertheless, the definition of a consensual core set of indicators remains
controversial and its practical use is largely limited. This study aims not only to identify and characterize these
indicators through a systematic literature review but also to propose a parsimonious model based on those most used.
Methods: MEDLINE, SCOPUS, Cochrane databases and ISI Web of Knowledge, as well as official websites of
organizations dealing with HIV/AIDS care, were searched for articles and information proposing HIV/AIDS clinical care
quality indicators. The ones that are on patient’s perspective and based on services set were excluded. Data extraction,
using a predefined data sheet based on Cochrane recommendations, was done by one of the authors while a second
author rechecked the extracted data for any inconsistency.
Results: A total of 360 articles were identified in our search query but only 12 of them met the inclusion criteria. We
also identified one relevant site. Overall, we identified 65 quality indicators for HIV/AIDS clinical care distributed as
following: outcome (n=15) and process-related (n=50) indicators; generic (n=36) and HIV/AIDS disease-specific (n=29)
indicators; baseline examinations (n=19), screening (n=9), immunization (n=4), prophylaxis (n=5), HIV monitoring
(n=16), and therapy (=12) indicators.
Conclusions: There are several studies that set up HIV clinical care indicators, with only a part of them useful to assess
the HIV clinical care. More importantly, HIV/AIDS clinical care indicators need to be valid, reliable and most of all feasible.
Keywords: Performance Measures, Quality Indicator, Infectious DiseaseBackground
Quality performance or quality of clinical care is the
main subject in the health care system and it can be pre-
cisely defined. Many studies have been made on this
subject [1-3]. The Institute of Medicine defined Quality
of care as the degree to which health services for indi-
viduals and populations increase the likelihood of de-
sired health outcomes and are consistent with current
professional knowledge [3,4]. This assessment can be* Correspondence: ecatumbela@med.up.pt
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distribution, and reproduction in any mediummade by measures that can give us the degree of quality
of care. Indicators are defined as a measurement tool
that can be used to monitor and evaluate the quality of
important governance, management, clinical, and sup-
ported functions [5]. They provide a quantitative basis
for clinicians, organizations, and planners aiming to
achieve improvement in care and in the processes by
which patient care is provided [6]. Donabedian and
Fleming related indicators to structure, process and out-
come [7]. Process indicators assess what the provider
did to the patient and if it was well done; it measures
the activities and tasks in patient episodes of care. Out-
come indicators measure the state of health or events
that follow care and that may be affected by health care.
In general, either process or outcome may be validtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Figure 1 Flow diagram for the search and selection of studies
for the systematic review.
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valid measure of quality, it must be closely related to
processes of care that can be manipulated to affect the
outcome. Likewise, for a process to be a valid measure
of quality, it must be closely related to an outcome that
people care about [4]. In many cases, there are multiple
factors that contribute to a patient’s survival and health
outcome. In those cases, it is useful that outcome mea-
sures are adjusted for factors like psychosocial character-
istics, lifestyle factors and severity of the illness, if we
want to make fair comparisons. Risk adjustment is useful
to control confounding factors that might contribute to
the outcome indicator [8].
Quality indicator – development and validation methods
Mainz says that for developing evidence-based clinical in-
dicators, it is necessary to follow certain steps, namely
choosing the clinical area to evaluate, organizing the
measurement team, providing an overview of existing evi-
dence and practice, selecting clinical indicators and stan-
dards, designing measure specification, and performing a
pilot test [8].
The pilot test aims to identify areas that require further
specifications of the quality measures. The validation
process determines the degree to which an indicator
measure, what is intended to measure, that is, whether the
results of measurement corresponds to the true state of
the phenomenon being measured [8], Figure 1.
Quality indicators - key characteristics
For each quality indicator it is important to verify if it meets
quality requirements such as validity, reliability, relevance
and applicability, based evidence [9,10], and the flexibility
of obtaining the indicator data [8]. The Agency for
Healthcare Research and Quality (AHRQ) uses the follow-
ing methods for identifying, selecting, and evaluating the
quality of the Inpatient Quality Indicators: face validity, pre-
cision, minimum bias, construct validity, fosters real quality
improvement, and application, mostly for determining the
reliability and validity of a quality indicator [11].
The assessment of the quality of care given to HIV/
AIDS patients has been a major focus of the HIV/AIDS
disease issue since 1990. Agins et al. [12] proposed a
model of indicators which assesses clinical care based on
tuberculosis (TB) screening, prophylactic therapy and
pneumocystis prophylaxis. Mallor et al. [13] proposed a
model which assesses the clinical care based on CD4+
count, viral load, as a marker of the evolution of the patient;
while Badri and Wood [14] suggested the usefulness of total
lymphocyte count in monitoring highly active antiretroviral
therapy in resource-limited settings. The New York State
Department of Health AIDS Institute [15] uses five indica-
tors to evaluate the quality of clinical care provided to pa-
tients with HIV / AIDS, namely: (a) Management ofAntiretroviral (ARV) Therapy, (b) Viral Load Monitoring,
(c) HIV Intrapartum Prophylaxis, (d) Tuberculosis Screen-
ing, and (e) Pelvic Examination. So, we may find different
types of indicators used to assess the quality of clinical care
given to HIV/AIDS patients.
In this study we performed a systematic review to
identify the current existing quality indicators, evidence-
based, used for monitoring and evaluating HIV/AIDS
impatient and outpatient clinical care, and, based on the
clinical relevance and practice utility, we propose a core
set of indicators, through observational studies.Methods
Data source
A systematic review (SR) of observational studies on
HIV/AIDS quality indicators for clinical care and its de-
velopment and validation methods, using electronic da-
tabases such as MEDLINE (1966–2012 through PubMed),
SCOPUS (2004–2012), Cochrane Collaboration database
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( −2012), without limitations of language. Additional
studies were identified by searching reference-lists of
articles and on the official institutions sites that work
with HIV/AIDS quality indicators.Search terms
We used the following search terms and Medical Subject
Headings (MeSH) to search observational studies: “ob-
servational studies”, “quality indicators”, “validation
studies”, “HIV/AIDS”. We developed a search query for
each database, and one of the 3 search-queries we set up
down can be seen in Table 1. At first, we found all sub
heading terms of observational studies and summarized
the results. We selected only studies that were carried
out on human and excluded those related to animals.
After that, we looked for quality indicators and HIV/AIDS
studies. This search strategy was based on Cochrane Re-
view recommendations [16].Inclusion and exclusion criteria
In this SR we included the primary studies that had met
the following criteria, (i) talk about HIV/AIDS clinical
care quality indicators, and (ii) set up a conceptual
model of quality indicators for HIV/AIDS in clinical care
context, or (iii) describe or validate HIV/AIDS clinical
care quality indicators.
We excluded studies that (i) are based only on services
set, (ii) are based on patient perspective or (iii) did not
provide sufficient details in methods and results sec-
tions, thus failing to answer research questions.Study selection
Eligibility assessment was performed independently by 2
reviewers based on inclusion criteria, and disagreements
between reviewers were solved by consensus.Data collection processes
We developed a data extraction sheet adapted to obser-
vational studies (based on Cochrane Consumers and
Communication review Group’s data extraction template),
we pilot-tested it on 2 included studies, and refined it ac-
cordingly. One reviewer extracted the following data from
included studies and the second checked the extracted
data: first author, year, publication country and study de-
sign, objective, number of clinical indicators and selection
criteria. For each indicator: name, type (process or out-
come), quality (generic or specific) selection and validation
criteria. Disagreements were solved by discussion between
the two reviewers. If no agreement could be reached, a
third author was planned but it was not necessary. We did
not contact any authors for further information.Data analysis
For each quality indicator of HIV clinical care some pa-
rameters were determined. Similar indicators were
grouped together. We classified indicators according to
the dimension of quality of care as process (referred to
the actions of healthcare providers, such as measuring
or screening), or outcome (the results actions of
healthcare providers, for instance, non-detectable viral
load at 48 treatment week) indicators as described by
Donabedian [7]. We also figured out if the American
[17] and European [18] guidelines endorsed each indica-
tor. The core set of HIV clinical care indicators was de-
fined by the ones that were simultaneously used in at
least two studies and were endorsed by both guidelines.
Results
Study selection
The search of MEDLINE, Cochrane, Scopus and ISI web
knowledge provided a total of 360 citations. After
adjusting for duplicates 343 remained. Of these, 329
studies were discarded after revision as the papers
clearly did not met the inclusion criteria. One study,
Bennet (1996) [19] was discarded because the full text of
the study was not available. The full texts of the
remaining 31 citations were examined in more detail. Of
those, 22 were excluded for being based on services set
(20) and on patient perspective (2). The remaining 9
studies met the inclusion criteria and were included in
the systematic review (SR). Two other studies were
added to the SR from the reference list. No unpublished
relevant studies were obtained. Two papers [20,21] are
from the same author and on the same subject and, for
that reason, we considered them as one study. As a result,
12 different studies were included for review. The flow
diagram for the study selection can be seen in Figure 1.
Web HIV/AIDS quality indicators search
On the internet, we looked for official sites and only one
met the inclusion criteria, namely the Indicator Registry
[22] owned by the World Health Organization through
United Nations General Assembly Special Session on
HIV/AIDS (UNGASS) and other agencies (World Health
Organization, UNICEF, the Global Fund to Fight AIDS,
Tuberculosis and Malaria, the U.S. President’s Emer-
gency Plan for AIDS Relief, and the UNAIDS Secretariat
and guided by the MERG that sets standards for indica-
tors and their use). This registry is a central repository
of information on indicators used to track the AIDS epi-
demic and the national, regional and global response,
with 184 indicators.
Studies characteristics
This systematic review covers a range of 23 years be-
tween the first and the last study, published in 2012.
Table 1 MEDLINE search query
Search Query Items
found
#71 Search #66 AND #70 21
#70 Search #67 OR #68 OR #69 144142
#69 Search HIV/AIDS[Title/Abstract] 17246
#68 Search AIDS[MeSH Terms] 70455
#67 Search HIV [MeSH Terms] 73266
#66 Search #59 AND #62 AND #65 6914
#65 Search #63 OR #64 11513
#64 Search Quality Indicators [Title/Abstract] 2617
#63 Search Quality Indicators, Healthcare [MeSH Terms] 10006
#62 Search #60 NOT # 61 15517434
#61 Search Human [MeSH Terms] 12128326
#60 Search Animal [MeSH Terms] 15794808
#59 Search #31 OR #58 6259659
#58 Search #32 OR #33 OR #34 OR #35 OR #36 OR #37
OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR
#44 OR #46 OR #47 OR #48 OR #49 OR #50 OR #51
OR #52 OR #53 OR #54 OR #55 OR #56 OR #57
5638100
#57 Search Outcome Assessment (Health Care)[MeSH
Terms]
64
#56 Search Outcome Assessment (Health Care) 116277
#55 Search Validation Studies [Publication Type] 54533
#54 Search Evaluation Studies [Publication Type] 162083
#53 Search Case Reports [Publication Type] 1566659
#52 Search Commission on Professional and Hospital
Activities[MeSH Terms]
206
#51 Search Commission on Professional and Hospital
Activities
282
#50 Search Models, Theoretical[MeSH Terms] 1073230
#49 Search Pilot Projects[Title/Abstract] 453
#48 Search Pilot Projects[MeSH Terms] 69739
#47 Search Research[Title/Abstract] 689721
#46 Search Research[MeSH Terms] 394473
#45 Search Statistics as Topic[MeSH Terms] 1664889
#44 Search Statistics as Topic 1695673
#43 Search Validation Studies as Topic[MeSH Terms] 913
#42 Search Validation Studies as Topic 6755
#41 Search Prospective Studies[Title/Abstract] 17555
#40 Search Prospective Studies[MeSH Terms] 312410
#39 Search Intervention Studies[Title/Abstract] 4683
#38 Search Intervention Studies[MeSH Terms] 5150
#37 Search Twin Studies as Topic[MeSH Terms] 1360
#36 Search Twin Studies as Topic 1784
#35 Search Evaluation Studies as Topic[MeSH Terms] 895895
#34 Search Evaluation Studies as Topic 906192
#33 Search Feasibility Studies[Title/Abstract] 535
#32 Search Feasibility Studies[MeSH Terms] 35041
Table 1 MEDLINE search query (Continued)
#31 Search #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7
OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14
OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR
#21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27
OR #28 OR #29 OR #30
1509215
#30 Search Longitudinal Studies[Title/Abstract] 9116
#29 Search Longitudinal Studies[MeSH Terms] 757612
#28 Search Retrospective Studies[Title/Abstract] 4389
#27 Search Retrospective Studies[MeSH Terms] 407740
#26 Search Sampling Studies[Title/Abstract] 126
#25 Search Sampling Studies[MeSH Terms] 18424
#24 Search Time and Motion Studies[Title/Abstract] 75
#23 Search Time and Motion Studies[MeSH Terms] 3137
#22 Search Multicenter Studies as Topic[MeSH Terms] 14178
#21 Search Multicenter Studies as Topic 20139
#20 Search Genetic Association Studies[Title/Abstract] 1533
#19 Search Genetic Association Studies[MeSH Terms] 10125
#18 Search Seroepidemiologic Studies[Title/Abstract] 193
#17 Search Seroepidemiologic Studies[MeSH Terms] 15564
#16 Search Follow-Up Studies[Title/Abstract] 8404
#15 Search Follow-Up Studies[MeSH Terms] 438403
#14 Search Cross-Over Studies[Title/Abstract] 284
#13 Search Cross-Over Studies[MeSH Terms] 29156
#12 Search Organizational Case Studies[Title/Abstract] 5
#11 Search Organizational Case Studies[MeSH Terms] 8339
#10 Search Cross-Sectional Studies[Title/Abstract] 3917
#9 Search Cross-Sectional Studies[MeSH Terms] 136893
#8 Search Epidemiologic Studies[Title/Abstract] 13538
#7 Search Epidemiologic Studies[MeSH Terms] 1388630
#6 Search Cohort Studies[Title/Abstract] 8010
#5 Search Cohort Studies[MeSH Terms] 1155017
#4 Search Case–control Studies[Title/Abstract] 8277
#3 Search Case–control Studies [MeSH Terms] 542455
#2 Search observational study[Title/Abstract] 24606
#1 Search observational studies 40232
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[20-28], one in Ethiopia [29], one in Spain [30], one in
Thailand [31], and other in Malawi [32]. According to
the study design, four are projects that aimed to develop
HIV quality indicators [22,23,27,30], three are cross-
sectional studies that aimed to assess the clinical care
given to HIV/AIDS patients [24,26,29], one is a retro-
spective cohort [20,21], one is a program evaluation[31],
and one is an observational cohort [28]. All studies
aimed to assess the quality of a HIV care program, and
the last one presents a conceptual model [32] aimed to
discuss the validity of indicators within routine programs
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tors were proposed by experts through a panel, and
others were taken from guidelines (see Table 2).
Quality indicators
From the 12 studies, 65 HIV clinical care quality indica-
tors related to process and outcome were retrieved. From
these 65 indicators, 29 are HIV/AIDS-specific and 36 are
generic indicators; 15 are related to outcome and 50 to
process indicators. These indicators cover the following
clinical care areas: Baseline evaluation (19), screening for
opportunistic diseases and STD (9), immunization (4),
prophylaxis (5), HIV monitoring (16), and therapy (12).
The boundaries of these clinical areas are not very well
delimitated, and therefore some indicators could be easily
changed from one to another area (Table 3).Table 2 Description of studies by author, year, country, study
selection criteria
Author year Country Study design Objective
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We analyzed the HIV/AIDS quality indicators studies
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[20,21,29], HIV clinical care [25,27-29], and quality of
care, looking for a symptom-based framework [24] or
for determining whether a selected set of indicators can
represent a single overall quality construct [26,32] or
mortality risk adjustment approach, according to institu-
tional performance [20].
Selection and validation methods
All studies refer the use of literature review for searching
HIV/AIDS quality indicators. Some were based on na-
tional guidelines for the treatment of patients with HIV/
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Table 3 Quality indicators for the assessment of HIV/AIDS clinical care by name, type, indicators, and selection criteria







1 CD4 cell count measurement P S + + [23,25,27,28,30,31]*
2 Appropriate viral load test timing P S + + [25,29,31]*
3 Renal basic assessment (Creatinine, Blood urea nitrogen, ) P G + + [20,31]
4 Complete blood count P G + + [20,23,31]*
5 Chemistry analysis (Serum LDH , Sodium, Venous bicarbonate,
Hypoxemia ratio, Serum albumin)
P G + - [24]
6 Proportion of patients with CD4 count greater than
200 cells/ul
O S + + [29,30]*
7 Bilirubin O G + + [24]
8 Admission body mass index O G - + [24]
9 Ask about loss of appetite P G - + [24]
10 Monitor patient’s weight P G - + [22,24]
11 CNS change O G - + [21]
12 Complicated cough O G - - [24]
13 Diarrhea O G - - [24]
14 Heart rate O G - + [24]
15 Rales O G - - [20]
16 Respiratory rate O G - - [21]
17 Lung examination P G + + [24]
18 ECG performed in patients on methadone P S - + [31]
19 Cardiovascular risk assessment P G - + [31]
B. Screening
20 Cervical cancer screening (basis and follow up) P G + + [26,28,30]*
21 Hepatitis C screening (basis and follow up) P G + + [25-27,31]*
22 Hepatitis B testing ever (basis and follow up) P G + + [25,27]*
23 Tuberculosis screening P G + + [22,23,25-28,30,31]*
24 Gonorrhea/chlamydia screening (at least once) P S - + [23,25,27]**
25 Syphilis screening (annually) P S - + [25,27,28,30,31]**
26 Injection drug use screening (annually) P G - + [23,27,28]**
27 High-risk sexual behavior screening (annually) P G - + [23,27,28]**
28 Papanicolau test in last year (for women only) P G - + [23,25]
C. Immunization
29 Pneumococcal vaccine in previous 6 months if CD4 >200 P G - + [25,27,28,31]**
30 Influenza vaccination (annually) P G - + [26-28]**
31 Hepatitis B vaccination first dose received (if appropriate) P G + + [25,27,28,31]*
32 Hepatitis A vaccination P G + + [28,31]*
D. Prophylaxis (patients with <200 lymphocyte CD4)
33 MAC prophylaxis P G - - [23,28]
34 PCP (pneumocystis jiroveci pneumonia) prophylaxis P G - - [23,25-28,30,31]
35 Toxoplasmosis prophylaxis P G - - [23,31]
36 TB prophylaxis if reactive PPD P G + - [25]
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Table 3 Quality indicators for the assessment of HIV/AIDS clinical care by name, type, indicators, and selection criteria
(Continued)
37 Cryptococcosis prophylaxis for patients with CD4 <100 cells/ul P G - - [30]
E. HIV Monitoring
38 Non-detectable HIV viral load at 48 treatment weeks O S + + [26,31] *
39 Proportion of patients who received their fist-time CD4 count
within 2 weeks after first HIV clinic visit
P S - - [28,29]
40 Proportion of patients eligible for ART who are currently on ART P S + + [29]
41 Proportion of patients on ART for whom adherence is measured
on last three visits
P S - - [29,31]
42 Proportion of patients on NVP who had LFT at least once within
1 month after initiation of NVP-based ART
P S - - [29]
43 Proportion of patients with previous ARV regimen change for whom
reason for change in regime is documented
P S + + [29,31] *
44 Proportion of patients on ARV with at least 95% (good) reported
adherence on last visit
O S + + [29,32] *
45 Achieving maximal viral control if prescribed ART O S + + [27]
46 Achieving maximal viral control if prescribed ART or treatment plan
documentation if maximal viral control not achieved.
O S + + [27]
47 proportion of patients with continued care P G + + [29,32] *
48 Visits in three quarters P G + - [26,28]
49 HIV counseling and test offered P S + + [23,31]*
50 Length of stay in hospital P G - - [20]
51 Loss of follow up P G + - [31,32]**
52 Percent HIV/AIDS hospital mortality O S - - [20]
53 HIV prevalence among pregnant women P S + + [22]
F. Therapy
54 Appropriately prescribed ART P S + + [22,23,25-28,30,31]*
55 Proportion of patients on cotrimoxazole prophylaxis with at least
95% reported adherence on last visit
P S - - [24,29]
56 Proportion of patients whose CD4 count is <350 cell/ul who are
currently on cotrimoxazole prophylactic therapy
P S - - [29]
57 In patients with at most CD4 count <200 cells/microliter Prescribe an
antibiotic or admit the patient to the hospital
P S - - [24]
58 Proportions of patients on ART who are started on ART within 2 weeks
after clinical eligibility is confirmed
P S + + [29]
59 Proportion of either bedridden or ambulatory patients who have
improvement in functional status
O S - + [29]
60 Proportion of HIV-positive clients given treatment for latent TB infection P S + + [22,30,31]*
61 Proportion of HIV-positive registered TB patients given ART during
TB treatment
P S + + [22]
62 Percent of HIV-positive patients in HIV care or treatment (pre-ART
or ART) who started TB treatment
P S + + [22,30]
63 Patient with HIV receiving Hepatitis C treatment P G + + [31]
64 Co-management of Tuberculosis and HIV Treatment P S + + [22]
65 Number of HIV-positive pregnant women who received antiretroviral
to reduce risk of mother-to-child-transmission
P S + + [22]
Type of indicator: P – Process (50) and O – Outcome (15); Quality indicator: S – specific (29) and G – generic (36). American and European HIV treatment
guidelines: (+) present; (−) absent.
Number of indicators by clinical area: A (19); B (9); C (4); D (5); E (16); F (12).
* Indicators that are in both guidelines and are used in more than one study.
** Indicators that are only in one guideline and are used in more than one study.
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Table 4 Core indicators proposed for the assessment of
the quality of HIV/AIDS clinical care
no. Name
A. Baseline evaluation
1 CD4 cell count measurement
2 Appropriate viral load test timing
4 Complete blood count
6 Proportion of patients with CD4 count greater than 200 cells/ul
B. Screening
20 Cervical cancer screening (basis and follow up)
21 Hepatitis C screening (basis and follow up)
22 Hepatitis B testing ever (basis and follow up)
23 Tuberculosis screening
24 Gonorrhea/chlamydia screening (at least once)
25 Syphilis screening (annually)
27 High-risk sexual behavior screening (annually)
28 Papanicolau test in last year (for women only)
C. Immunization
31 Hepatitis B vaccination first dose received (if appropriate)
34 PCP (pneumocystis jiroveci pneumonia) prophylaxis
E. HIV Monitoring
38 Non-detectable HIV viral load at 48 treatment weeks
43 Proportion of patients with previous ARV regimen change for
whom reason for change in regime is documented
44 Proportion of patients on ARV with at least 95% (good) reported
adherence on last visit
47 proportion of patients with continued care
49 HIV counseling and test offered
F. Therapy
54 Appropriately prescribed ART
55 Proportion of patients on cotrimoxazole prophylaxis with at least
95% reported adherence on last visit
60 Proportion of HIV-positive clients given treatment for latent TB
infection
62 Percent of HIV-positive patients in HIV care or treatment
(pre-ART or ART) who started TB treatment
Catumbela et al. BMC Health Services Research 2013, 13:236 Page 8 of 11
http://www.biomedcentral.com/1472-6963/13/236identify specific processes of care that a clinician would
be expected to perform for HIV patients presenting par-
ticular symptoms [23,24]. In one study [20,21] there is
no clear description of the methods used to select the
quality indicators.
In the validation phase of three studies, the proposed in-
dicators were revised after discussion by physicians who
were working on an HIV/AIDS control program as well as
HIV care-providing facilities, for their local relevance and
retained only the indicators where consensus was achieved
[22,27-29,31]. In other six studies there was no reference
to validation. The main characteristic of all studies is the
quality of care assessment and not the approach to the
validity of HIV/AIDS quality indicators.
From the internet search, we identified one official site
that has a core set of HIV/AIDS indicators, and we re-
trieved 22 indicators that met our inclusion criteria. For
each indicator we read the definition and what it mea-
sures, the data type, and the indicator type level to find
out the ones we could use to assess hospital care. Nine
quality indicators can be used to assess HIV/AIDS clin-
ical care. Five are related to co-management of HIV and
TB, two are related to the care of pregnant woman, and
two are related to HIV care itself. Six are process related
and 3 are outcome indicators.
To answer the question, “What core indicators are
useful to assess HIV clinical care?”, we made a selection
process through observation of indicators that are used
in more than one study, are not the same or do not as-
sess the same situation, and are endorsed by both
American and European guidelines; for the treatment of
HIV we found 21 HIV/AIDS quality indicators that can
be used to assess the clinical care (Table 4).
Discussion
In this review we wanted to find out what HIV/AIDS
quality indicators are used to assess clinical care, their
development and validation methods. We found few
studies. Most of them are process or outcome indicators
and, as Mainz defined, “process denotes what is actually
done in giving and receiving care and outcomes mea-
sures attempt to describe the effects of care on the pa-
tients’ health status and populations” [10]. So, through
this review, we have an overview of the most relevant as-
pects that we have to look at when assessing HIV clinical
care. The methods used (guidelines and expert panels)
to select them are according to what is described in the
literature [8,9,33], nevertheless, little information has
been given about their validation methods.
We found 50 process indicators that assess different
aspects of HIV/AIDS hospital care. Wollersheim et al.
[9] say that there is some conflict between the number
of indicators selected and the amount of work which
must be spent on recording data. They argue that toachieve a good balance, it is recommended to select
about 12 clinical indicators for care process.
Attempting to establish the core set of indicators use-
ful to assess HIV/AIDS clinical care, we compared the
quality indicators we got with the American and
European guidelines. For some indicators, there is no
doubt about their relevance, they are in both guidelines
and in more than one study, for instance, CD4 count
cell, viral load; for others, the difference is that they are
only in one guideline, but this doesn’t make them less im-
portant. Indicators like syphilis or gonorrhea screening are
also very important even though they are not endorsed by
the American guideline. The fact of the matter is that
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Another important aspect in this comparison between in-
dicators studies and guidelines is that there are some indi-
cators that are in both guidelines, but are only mentioned
by one study. For instance, knowing the “Proportion of pa-
tients eligible for ART who are currently on ART” is as
important as knowing if they have prescribed appropriate
ART. Defining a core set of indicators is a hard task.
In Table 4, we have the core set of indicators we think
that can be used to approach HIV/AIDS clinical care.
Some specific HIV clinical care indicators used are: CD4
cell count, viral load test, non-detectable HIV viral load
at 48 treatment weeks, Hepatitis C screening, Hepatitis
B testing, Tuberculosis screening, Hepatitis B vaccin-
ation, PCP (pneumocystis jiroveci pneumonia) prophy-
laxis, adherence to ART, appropriately prescribed ART,
and HIV-TB co-treatment. All these measures are con-
sidered to be critical elements in the clinical care of indi-
viduals with HIV/AIDS [25], and they have clinical
utility because they are endorsed by guidelines [17,18].
In the core of indicators that we propose, only 3 of the
23 are outcome indicators. Although it is desirable to
obtain outcome indicators it is not always possible, due
to: firstly, there are many processes that compete for the
same outcome [34]; secondly, due to the time needed to
obtain the desired result, surrogate measures are used;
thirdly, data limits often dictate the extent of the mea-
sures that can be established or are not suitable to every
HIV-infected patient. Unless a measure addresses poten-
tial pitfalls adequately, the results produced from the
measure may be misleading rather than helpful [35].
Some indicators are obtained from a set of steps which
includes more than one data element, or are influenced
by many factors, such as age or gender (adjustment mea-
sures). One of the challenges hospitals face nowadays is
the quality of the data they collect [36-38]. Some vari-
ables can have missing values, can be biased (for in-
stance, because of their main purpose), or may not be
possible to collect, and so adjustments can be difficult.
Nevertheless the dissemination of indicators throughout
regions and hospitals should help them to understand
the key elements of HIV/AIDS care that will be under
scrutiny, and thereby encourage hospitals to implement
data management systems that facilitate measurement of
their HIV/AIDS care process and patient outcomes.
When we analyze the validity of the quality indicators,
a common characteristic is that most of the studies as-
sess the quality of care, only one is about the validity of
the quality indicator itself. So for each indicator, it is ne-
cessary to analyze it in order to find out its reliability,
relevance and applicability.
Indicators included in the WHO Indicator and Meas-
urement Registry are set up “on a national basis”; some
of them can be applied at a local level, but few of themare to assess the quality of HIV clinical care. These indi-
cators are well defined and are ready to be used by
everyone as they are valid and reliable.
Future works
Many institutions have been using HIV/AIDS quality
indicators to assess the quality of clinical care and
make a benchmarking between caregivers. The results
seem to be good, and improvement of care has been
achieved [25,26].
Quality care indicators or clinical care indicators are
used in many situations, as the ones described next. (1)
To improve the quality of care, for instance Asch at al.
[24], used a symptom-based framework and their results
suggested that symptom-based measures of quality may
measure domains that are distinct from those captured
by conventional indicators. The matter is that nowadays,
when using TARV, many symptoms are more scarce un-
less people are run out of the healthcare system. While
Thanprasertsuk et al. [31] used the quality indicator to
improve the quality of care, they compared one setting
before and after using quality indicators, and the im-
provement of quality of clinical care rose from 0 to 95%
of accomplishment. (2) To figure out if the system is de-
livering clinical care, according to the guidelines. Here
we noted that Alemayehu et al. [29], focused their work
on assessing the accomplishment of the guidelines
through process and outcome measures. They pointed
out the need for regular monitoring and improvement
of processes and outcomes of care in order to achieve
good results. (3) To compare institutions or services
(benchmarking). Wilson et al. [26], looked through 69
sites from 30 states to determine whether a selected
set of indicators can represent a single overall quality
construct. The main result of this study was that it is
necessary to define a core set of indicators in order to
compare sites fairly.
The next step is to test the measures in real data, to
find out the reliability of each indicator and to validate a
set core of quality indicators that can be used to assess
HIV clinical care and may be used to compare services,
hospitals or even countries.
This review had several limitations. Although we
found few studies, we made a wide search on the web
using multiple terms and databases. Search in gray lit-
erature was limited. Studies in languages other than
English were not included. Anyway, as far as we know,
there is no other published systematic review about
HIV/AIDS quality indicators for clinical care assessment,
and we summarized here a vast and wide set of informa-
tion. The fact of the matter is that we include experi-
ences from USA, Ethiopia, Malawi, Spain and Thailand,
and a core of organizations that work on the HIV/AIDS
field under the WHO umbrella.
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We wanted to identify a core set of indicators that repre-
sent optimal care and that will facilitate uniform meas-
urement and benchmarking of the quality of HIV/AIDS
clinical care at a local level, and can lead to the estab-
lishment of comparative reporting between developed
and developing countries.
The main findings of this systematic review are that
there are efforts from the USA and Spain to establish a
national core set of indicators useful to assess the HIV/
AIDS clinical care; the assessment of HIV/AIDS clinical
care must take into account the main aspects of baseline
assessment, screening, immunization, prophylaxis, HIV
monitoring, and therapy. Most of the indicators are
process-related, are intended to guide (the good prac-
tice) and to evaluate the clinical care provided to HIV/
AIDS patients.
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